Bimekizumab versus Ustekinumab Efficacy Across Subgroups of Patients with Moderate to Severe Plaque Psoriasis: Results from the Multicenter, Randomized, Double-Blinded Phase 3 BE VIVID Trial
2021 ◽
Vol 5
(1)
◽
pp. s16
B Strober
◽
JG Krueger
◽
N Magnolo
◽
R Vender
◽
DP Toth
◽
...
2021 ◽
Vol 85
(3)
◽
pp. AB76
Bruce Strober
◽
Richard B. Warren
◽
Peter Foley
◽
Melinda Gooderham
◽
Diamant Thaçi
◽
...
2021 ◽
Vol 5
(1)
◽
pp. s15
RB Warren
◽
A Blauvelt
◽
J Bagel
◽
KA Papp
◽
P Yamauchi
◽
...
2020 ◽
Vol 4
(6)
◽
pp. s82
K Reich
◽
K Papp
◽
A Blauvelt
◽
R Langley
◽
A Armstrong
◽
...
2020 ◽
Vol 4
(6)
◽
pp. s83
K Gordon
◽
P Foley
◽
JG Krueger
◽
A Pinter
◽
K Reich
◽
...
Andrew Blauvelt
◽
Kim A Papp
◽
Joseph F Merola
◽
Alice B Gottlieb
◽
Nancy Cross
◽
...
Atsuyuki Igarashi
◽
Hidemi Nakagawa
◽
Akimichi Morita
◽
Yukari Okubo
◽
Shigetoshi Sano
◽
...
D Thaçi
◽
AM Soliman
◽
K Eyerich
◽
A Pinter
◽
M Sebastian
◽
...
2020 ◽
Vol 83
(6)
◽
pp. AB31
Shaojun Tang
◽
Arnaud Amzallag
◽
Robert Yang
◽
Peter H. Schafer
2021 ◽
Vol 20
(3)
◽
pp. 252-258
Seemal Desai
◽
Brad Glick
◽
James Del Rosso
◽
Susan Harris
◽
Abby Jacobson
2017 ◽
Vol 34
(6)
◽
pp. 1327-1339
◽
Sandra Adsit
◽
Enrique Rivas Zaldivar
◽
Howard Sofen
◽
Ignacio Dei-Cas
◽
César Maldonado-García
◽
...
Close
Export Citation Format
Close
Share Document
Close